TY - JOUR
T1 - Controlled Adverse Environment Chambers in Dry Eye Research
AU - Calonge, Margarita
AU - Labetoulle, Marc
AU - Messmer, Elisabeth M
AU - Shah, Sunil
AU - Akova, Yonca A
AU - Boboridis, Kostas G
AU - Merayo-Lloves, Jesús
AU - Aragona, Pasquale
AU - Benítez-Del-Castillo, José
AU - Geerling, Gerd
AU - Rolando, Maurizio
AU - Baudouin, Christophe
PY - 2018/4
Y1 - 2018/4
N2 - Dry eye disease (DED) is a common condition with signs and symptoms that vary depending on a wide range of environmental factors to which people are exposed in their daily lives. Factors such as variable temperature, airflow velocity, relative humidity, seasonality, and pollutants can alter the rate of tear film evaporation, improving or exacerbating symptoms of DED. Results from currently available clinical tests do not always correlate well with patient-reported symptoms, and the continually changing environment and variability in DED symptoms present challenges for the design and conduct of clinical trials. Controlled adverse environment chambers allow standardization of temperature, humidity, and airflow and may minimize potential confounding factors in clinical investigations. Their use can promote accurate study of the pathophysiology of DED, discovery of disease biomarkers, and assessment of the effect of various therapeutic approaches on patients' symptoms. Controlled adverse environment chambers have been used to simulate indoor surroundings such as airplane cabins and to test their effects on contact lens wearers. This review summarizes how these chambers may be useful for the development, approval, and differentiation of potential new treatments for DED.
AB - Dry eye disease (DED) is a common condition with signs and symptoms that vary depending on a wide range of environmental factors to which people are exposed in their daily lives. Factors such as variable temperature, airflow velocity, relative humidity, seasonality, and pollutants can alter the rate of tear film evaporation, improving or exacerbating symptoms of DED. Results from currently available clinical tests do not always correlate well with patient-reported symptoms, and the continually changing environment and variability in DED symptoms present challenges for the design and conduct of clinical trials. Controlled adverse environment chambers allow standardization of temperature, humidity, and airflow and may minimize potential confounding factors in clinical investigations. Their use can promote accurate study of the pathophysiology of DED, discovery of disease biomarkers, and assessment of the effect of various therapeutic approaches on patients' symptoms. Controlled adverse environment chambers have been used to simulate indoor surroundings such as airplane cabins and to test their effects on contact lens wearers. This review summarizes how these chambers may be useful for the development, approval, and differentiation of potential new treatments for DED.
KW - Dry Eye Syndromes/epidemiology
KW - Environment, Controlled
KW - Environmental Exposure/adverse effects
KW - Global Health
KW - Humans
KW - Humidity
KW - Incidence
KW - Seasons
KW - Temperature
UR - https://www.tandfonline.com/doi/full/10.1080/02713683.2017.1420197
U2 - 10.1080/02713683.2017.1420197
DO - 10.1080/02713683.2017.1420197
M3 - Review article
C2 - 29336696
SN - 0271-3683
VL - 43
SP - 445
EP - 450
JO - Current Eye Research
JF - Current Eye Research
IS - 4
ER -